Scientific collaborations

We are thankful to our present and past collaborators.

We work closely with other groups at EMBL, including Peer Bork, Alvis Brazma,  Jeroen KrijgsveldChristoph Merten, and Carsten Schultz

We also have multiple interactions with our neighbour Wellcome Trust Sanger Insitute, in particular Jyoti ChoudharyAntonio Vidal-Puig, Mathew Garnett and Ultan McDermott.

We also work with groups all over the world, including (in alphabetic order): 

Ruedi Aebersold, ETH Zurich, Switzerland
Leonidas G. Alexopoulos, National Technical University of Athens, Greece
Gary Bader, University of Toronto, Canada
Julio Banga, (Bio)Process Engineering Group, CSIC, Spain
Cyril Benes, Massachusetts General Hospital, Boston, US
Gianni Cesareni, University of Rome Tor Vergata, Italy
Pedro R. Cutillas, Imperial College, UK
Christian Frezza, MRC, Cambridge
Thorsten Hagemann and Fran Balkwill, Barts Cancer Institute, UK
Steffen Klamt, Max Planck Institute, Germany
Douglas Lauffenburger, Massachusetts Institute of Technology, US
Alexander Mitsos, RTWH Aachen, Germany
Miguel Angel Pujana, IDIBELL, Spain
Miguel Rocha, University of Minho, Portugal
Anne Siegel, INRIA/IRISA, France
Peter K. Sorger, Harvard Medical School, US
Gustavo A. Stolovitzky, IBM, US, as part of the DREAM project
Pablo Villoslada, IDIBAPS - Hospital Clinic of Barcelona, Spain
Lodewyk Wessels, Netherlands Cancer Institute, The Netherlands

 

We are also thankful of interactions and support from industrial partners, in particular Sanofi-Aventis and Glaxo-Smith-Kline

With thanks to our funders